title: Inhibitory effect of Kangjia Pill on thyrocyte proliferation in rat goiter model.
abstract: OBJECTIVE
  To investigate the inhibitory effects of Kangjia Pill (KJP) on the cell proliferation in rat goiter model induced by methimazole (MMI).
  
  
  METHODS
  Fifty-six Wistar rats were randomly divided into four groups: the normal group, MMI model group (MMI), low dose of KJP group (LKJP), and high dose of KJP (HKJP). Except the normal group (20 rats), the other groups (12 rats in each) were given 0.04% (w/v) MMI through the drinking water until the end of the experiment. One week later, the rats in the LKJP and HKJP groups were given KJP by gastrogavage at the dose of 250 mg/(kg x d) and 1,000 mg/(kg x d), respectively for 12 weeks. The relative thyroid weight (mg/100 g body weight) of each rat was accessed. The expression of proliferating cell nuclear antigen (PCNA) was determined by immunohistochemistry, and the correlation analysis between the PCNA positive thyrocytes and the relative thyroid weight was performed. The expressions of PCNA and cyclin D1 were examined with Western blotting.
  
  
  RESULTS
  After KJP treatment for 12 weeks, compared with the MMI group, the relative thyroid weight of the HKJP group decreased significantly, and the positive thyrocyte populations of PCNA in the two KJP groups reduced markedly (all P<0.05). The correlation analysis showed that PCNA was closely correlated with thyrocyte proliferation (r=0.685, P<0.05). KJP significantly decreased the protein expression of PCNA and cyclin D1 in the thyroid specimens (P<0.05), the high dose showed better effects.
  
  
  CONCLUSIONS
  KJP played a therapeutic role via inhibiting cell proliferation in the rat goitrous glands.
authors.affiliation: Department of Endocrinology, Provincial Hospital Affiliated to Shandong University, Jinan, 250021, China.
authors.forename: Yong
authors.initials: Y
authors.lastname: Han
authors.forename: Jing
authors.initials: J
authors.lastname: Zhou
authors.forename: Shu-jing
authors.initials: SJ
authors.lastname: Yu
authors.forename: Bin
authors.initials: B
authors.lastname: Cui
authors.forename: Hai-qing
authors.initials: HQ
authors.lastname: Zhang
authors.forename: Ling
authors.initials: L
authors.lastname: Gao
authors.forename: Jia-jun
authors.initials: JJ
authors.lastname: Zhao
mesh_terms: D000818:Animals; D049109:Cell Proliferation / Q000187:drug effects*; D019938:Cyclin D1 / Q000378:metabolism; D004195:Disease Models, Animal; D015536:Down-Regulation / Q000187:drug effects; D004353:Drug Evaluation, Preclinical; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage* / Q000494:pharmacology; D006042:Goiter / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008713:Methimazole; D009929:Organ Size / Q000187:drug effects; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D013607:Tablets; D013961:Thyroid Gland / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology*
chemical_list: C530106:Ccnd1 protein, rat; D004365:Drugs, Chinese Herbal; D018809:Proliferating Cell Nuclear Antigen; D013607:Tablets; C545319:kangjia; D019938:Cyclin D1; D008713:Methimazole
references.citation: Thyroid. 2000 Sep;10(9):741-6
references.pmid: 11041450
references.citation: Genes Dev. 1993 May;7(5):812-21
references.pmid: 8491378
references.citation: Mol Cell Biol. 1995 Aug;15(8):4215-24
references.pmid: 7623816
references.citation: J Clin Endocrinol Metab. 1998 Jun;83(6):2192-8
references.pmid: 9626159
references.citation: J Histochem Cytochem. 1993 Jan;41(1):1-6
references.pmid: 7678022
references.citation: Nat Genet. 2001 Feb;27(2):195-200
references.pmid: 11175789
references.citation: Crit Rev Toxicol. 1993;23(1):77-109
references.pmid: 8097093
references.citation: Int J Cancer. 1998 Jun 10;76(6):806-11
references.pmid: 9626345
references.citation: Cancer. 1993 May 1;71(9):2807-12
references.pmid: 8096795
references.citation: Endocrinology. 1998 Aug;139(8):3646-53
references.pmid: 9681519
references.citation: Nature. 1987 Apr 2-8;326(6112):517-20
references.pmid: 2882424
references.citation: Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1433-8
references.pmid: 9990041
references.citation: Clin Exp Immunol. 2001 May;124(2):197-207
references.pmid: 11422195
references.citation: J Pathol. 2004 Apr;202(4):446-55
references.pmid: 15095272
references.citation: Exp Cell Res. 1995 Sep;220(1):220-5
references.pmid: 7664838
references.citation: Curr Opin Cell Biol. 2003 Apr;15(2):158-63
references.pmid: 12648671
references.citation: Thyroid. 2001 Jul;11(7):709-10
references.pmid: 11484902
references.citation: Jpn J Clin Oncol. 2003 Apr;33(4):173-9
references.pmid: 12810831
references.citation: Endocrinology. 1996 May;137(5):2036-42
references.pmid: 8612545
references.citation: Am J Surg Pathol. 1991 Aug;15(8):764-8
references.pmid: 1676880
references.citation: Fen Zi Xi Bao Sheng Wu Xue Bao. 2006 Apr;39(2):118-22
references.pmid: 16944582
references.citation: Nihon Jibiinkoka Gakkai Kaiho. 1993 Apr;96(4):651-8
references.pmid: 8099609
references.citation: J Huazhong Univ Sci Technolog Med Sci. 2005;25(6):625-8
references.pmid: 16696308
references.citation: J Cell Sci. 2003 Aug 1;116(Pt 15):3051-60
references.pmid: 12829735
references.citation: Am J Physiol. 1997 Jun;272(6 Pt 1):L1205-10
references.pmid: 9227524
references.citation: Mol Cell Biol. 2006 Mar;26(6):2387-98
references.pmid: 16508013
references.citation: Oncogene. 2003 Oct 9;22(44):6959-69
references.pmid: 14534545
references.citation: Acta Histochem. 1997 Nov;99(4):391-9
references.pmid: 9429599
references.citation: Am J Pathol. 1991 May;138(5):1165-72
references.pmid: 1673821
references.citation: J Mol Med (Berl). 2006 Nov;84(11):967-73
references.pmid: 16947002
references.citation: Anat Embryol (Berl). 1998 Dec;198(6):439-50
references.pmid: 9833684
references.citation: J Endocrinol. 2000 Mar;164(3):323-30
references.pmid: 10694372